Skip to content
healthcare.dev

TREANDA

NDC 63459-391, Bendamustine Hydrochloride, injection, powder, lyophilized, for solution, from Cephalon, LLC.

Product NDC
63459-391
Status
Listed
Labeler
Cephalon, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022249
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63459-391 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENDAMUSTINE HYDROCHLORIDE100 mg/20mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
63459-391-20634590391201 VIAL, SINGLE-DOSE in 1 CARTON (63459-391-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/39d53698-57fa-7c99-fc5b-f52a55684826
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63459-391

Use it

Look up 63459-391 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63459-391 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63459-391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.